
Founders
Njalsgade 19, Copenhagen, Hovedstaden, 2300, Denmark
Overview
We are a first-money and incubation investor. We partner with people with whom we share a vision, and work together to figure out how to get there. We will never say “come back when you have traction”. If we like the WHY and the WHO, the WHAT and HOW is what we figure out together.
- Total investments
- 21
- Lead investments
- 6
- Investments · 12mo
- 2
- Active investors
- 8
Sector focus
- Business Development
- Financial Services
- Venture Capital
Investment portfolio
- Motley
Participated · Seed · Nov 2025
Motley offers an AI business-reporting platform that connects to an organisation’s existing data sources—such as CRMs, BI tools, databases, and spreadsheets—to automatically gather information, generate report-ready documents, and surface contextual insights. By reducing reporting time from weeks to minutes, the software allows teams to shift their focus from data compilation to decision-making. The system also preserves historical context, runs sentiment analysis, and delivers recommendations that enrich recurring business reviews, customer updates, and performance reports. Early design partners and customers include Gigs, Evalart, and Impactpilot, validating initial market demand. Motley was founded by Egor Kraev, Artemy Belousov, and Yann Ranchere, who previously held senior roles at Wise, Yandex, and Anthemis respectively. With fresh capital, the company plans to accelerate product development, expand integrations, and scale its go-to-market activities. Motley is headquartered in Switzerland and positions its product to streamline collaboration and make business reporting more actionable.
- Propane
Participated · Seed · Aug 2025
Founded in 2025 and based in Copenhagen, Propane is developing an AI-native insights engine positioned as a next-generation Customer Data Platform to replace fragmented customer data systems. The platform actively learns from a broad spectrum of customer and company signals to deliver continuous intelligence for product and growth teams. Propane is starting with AI-powered, voice-based interviews as its entry product to capture qualitative insights at scale. The company emphasizes fully automated, deeply contextual, agentic AI that enables end-to-end qualitative interviews and instant, actionable answers. Propane announced a €1.2 million pre-Seed round and plans to use the funds to accelerate product development and grow its early customer base. The founding team includes alumni from Pleo, Neurons, Brandwatch and other companies and positions itself as an AI-native execution team.
- DreamPark
Participated · Seed · May 2025
DreamPark transforms physical locations into immersive mixed-reality environments using access points (physical markers like QR codes) that unlock digital overlays when scanned with a Meta Quest headset or mobile device. The company has live installations at Santa Monica’s Third Street Promenade and The LA County Fair, with planned expansions in Seattle, Orange County, and at expos and corporate events. DreamPark emphasizes a low-cost, location-based model that requires no construction or permanent infrastructure and claims its experiences can pay for themselves in the first month of revenue. The firm is positioning itself to capture early advantage in the XR live event market, which the article values at $3.6 billion in 2024 and projects to $190.3 billion by 2034. Near-term plans funded by the seed round include deploying additional access points, launching partnerships with major IP holders for branded experiences, expanding a nationwide fleet of rental Quest headsets, and growing the development team. The leadership team includes co-founders Brent Bushnell, Aidan Wolf, and Kevin Habich with backgrounds at Two-Bit Circus, Smiley Cap, and SNAP, Inc.
- Sibill
Participated · Equity · Jun 2024
Sibill offers a single platform that centralises invoices, payments, and deadlines for Italian SMEs and integrates banking cashflows and the Agenzia delle Entrate exchange system. The company leverages AI to automate manual tasks, provide real-time cashflow visibility, and help businesses save time and keep accounts organised. Sibill serves over 2,600 clients across Italy and reports customers save an average of five hours per week. The team is 50+ people and the company aims to double in size by the end of 2025. Management says it will use new capital to strengthen platform development, add features, and build strategic partnerships to support growth. Sibill is a Milan-based fintech that launched its product in 2023 and offers a suite of tools for e-invoicing, cashflow management, payment scheduling, and end-of-month reconciliation. The software is designed to enable smoother cooperation between SMBs and their accountants. The company cites strong tailwinds from Italy’s requirement that all B2B and B2G invoicing flows be digital, pointing to an addressable market of over 4 million Italian companies. Management says Sibill has seen strong uptake and a growing customer count. The firm secured €6.2M across two tranches and will use the proceeds to further develop its payments platform. Leadership intends to leverage the funding to pursue rapid expansion in the Italian SMB FinOps market and become a national champion.
- EXO Biologics
Participated · Series A · Apr 2024
EXO Biologics, based in Liège, Belgium, develops therapeutics built on exosomes and operates a proprietary ExoPulse production platform. Its lead candidate, EXOB-001 (umbilical cord‑derived MSC exosomes), targets prevention of bronchopulmonary dysplasia (BPD) in preterm newborns and has received Rare Pediatric Disease and Orphan Drug designations from the FDA and ODD from the EMA. The company has launched the EMA‑authorised EVENEW clinical trial for EXOB-001 and is pursuing therapeutic applications across respiratory, inflammatory bowel, neurology, and oncology indications. EXO Biologics also operates ExoXpert, a CDMO leveraging ExoPulse to provide GMP clinical‑grade exosomes for third parties. Future plans include advancing clinical trials, upgrading and expanding the ExoPulse platform, exploring exosomes as delivery vehicles for RNAs, proteins and small molecules, and expanding commercial and manufacturing partnerships. Financially, the company completed a Series A funding package totalling up to €16M to support these development and manufacturing efforts.